ICare4Autism is holding a very special gala reception on Thursday, 7th of June, 2012. The gala is in honor of Dr. Eric Hollander, Director of the Autism Spectrum Disorder Program at Montefiore Medical Center/Albert Einstein College of Medicine.
Attendees will also have the opportunity to learn more about plans for world’s first Global Autism Center, which will open on a five acre campus on Mt. Scopus in Jerusalem, in 2015.
The Suggested Donation is $500. You can RSVP and see more information about the event by clicking here.
Dr. Hollander, who chairs ICare4Autism’s International Advisory Board, will receive ICare4Autism’s coveted Global Autism Research Award for his breakthrough research in autism treatment.
Dr. Hollander received his B.A. from Brandeis University (1978), and his M.D. from SUNY Downstate Medical College, Brooklyn (1982). He completed his internship in Internal Medicine at Mt. Sinai Hospital (1983), residency and chief resident in psychiatry at Mt Sinai School of Medicine (1986), and his NIMH research fellowship at Columbia University College of Physicians and Surgeons (1988). He was appointed Associate Professor of Psychiatry at Columbia University College of Physicians and Surgeons. He joined the faculty of Mount Sinai School of Medicine in 1993, and was the Esther and Joseph Klingenstein Professor and Chair of Psychiatry at the Mount Sinai School of Medicine.
Dr. Hollander has served as the principal investigator for a number of federal grants, including the NIH Greater New York Autism Center of Excellence, the NIMH Research Training Grant in Psychopharmacology and Outcomes Research, and an FDA funded multicenter treatment trial of pediatric body dysmorphic disorder. He was the principal investigator of the autism Clinical Trials Network, and Chair of the eight centers NIH STAART Autism Steering Committee. He is involved in research on the neuropharmacology, neuropsychiatry, functional imaging, and treatment of obsessive-compulsive disorder, impulsive/aggressive personality disorders, obsessive-compulsive-related disorders such as body dysmorphic disorder, pathological gambling, and autism.
Dr. Hollander has received a Research Scientist Development Award from the National Institute of Mental health to investigate the psychobiology of obsessive-compulsive and related disorders. He has received orphan drug grants from the Food and Drug Administration to study new treatments for body dysmorphic disorder, child/adolescent autism, and adult autism, and a grant from the National Institute of Drug Abuse for a study on the neurobiology of pathological gambling. He has received several grants from the National Institute of Mental Health, and the National Institute of Neurological Disorders and Stroke, to develop treatments for borderline personality disorder, adolescent body dysmorphic disorder, and autism. Dr. Hollander has received two national research awards from the American Psychiatric Association and a Distinguished Investigator Award from the National Alliance for Research in Schizophrenia and Depression.